MKI67 and cervical cancer: This investigation also demonstrated that young women below 25 years screened by primary HPV and triage with p16/Ki67 histologic HSIL biomarker might benefit from introducing this more sensitive screening algorithm, especially in the light of new data on the cervical cancer rates elevation in younger groups of women in countries with very high HDI.